SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-020854
Filing Date
2020-02-14
Accepted
2020-02-14 08:53:54
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tm207976-3_sc13g.htm SC 13G 71067
  Complete submission text file 0001104659-20-020854.txt   72584
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87209 | Film No.: 20614293
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 THIRD AVENUE 6TH FL NEW YORK NY 10017
Business Address 767 THIRD AVENUE 6TH FL NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

IRS No.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G